Expert recommendations on poly-L-lactic acid and hyaluronic acid filler for labia majora and mons pubis: addressing skin laxity and volume restoration
- Obstetrics & Gynecology International Journal
-
Dóris Hexsel MD,<sup>1</sup> Alessandra Haddad MD PhD,<sup>2</sup> Maria Oneide Teixeira Alves MD,<sup>3</sup> Maria Paula del Nero MD,<sup>4</sup> Eliandre Palermo MD,4 Christine Munia MD,<sup>4</sup> Meire Parada MD,<sup>4</sup> Monica Manela-Azulay MD PhD,<sup>5</sup> Rafael Tomaz Gomes MD PhD,<sup>6</sup> Cristhine Kamamoto MD PhD,<sup>6</sup> Alessandra Nogueira MD<sup>6</sup>
PDF Full Text
Abstract
Introduction: Women’s concern with the aesthetic appearance of the vulva is not new, and the demand for genital rejuvenation procedures has consistently increased over the past decades.
Objective: To present recommendations from experts panel focusing on labia majora (LM) and mons pubis (MP) soft tissue augmentation and skin flaccidity improvement considering injectable hyaluronic acid (HA) and poly-l-lactic acid (PLLA-SCA), respectively.
Methods: A Brazilian expert-panel composed by six dermatologists, one gynecologist and one plastic surgeon proposed recommendations for soft tissue augmentation and skin flaccidity treatment of the LM and MP areas.
Results: The primary age groups seeking female genital rejuvenation typically include women in the perimenopausal period, younger patients who have experienced significant weight loss following bariatric surgery, and individuals who have recently changed sexual partners. The panelists categorized the indications into three main components: trophic, functional, and aesthetic.
Conclusion: This manuscript summarizes expert recommendations for soft tissue augmentation (injectable HA) and skin flaccidity treatment (PLLA-SCA) of the LM and MP.
Objective: To present recommendations from experts panel focusing on labia majora (LM) and mons pubis (MP) soft tissue augmentation and skin flaccidity improvement considering injectable hyaluronic acid (HA) and poly-l-lactic acid (PLLA-SCA), respectively.
Methods: A Brazilian expert-panel composed by six dermatologists, one gynecologist and one plastic surgeon proposed recommendations for soft tissue augmentation and skin flaccidity treatment of the LM and MP areas.
Results: The primary age groups seeking female genital rejuvenation typically include women in the perimenopausal period, younger patients who have experienced significant weight loss following bariatric surgery, and individuals who have recently changed sexual partners. The panelists categorized the indications into three main components: trophic, functional, and aesthetic.
Conclusion: This manuscript summarizes expert recommendations for soft tissue augmentation (injectable HA) and skin flaccidity treatment (PLLA-SCA) of the LM and MP.
Keywords
polylactic acid, polyglycolic acid copolymer, hyaluronic acid, dermal fillers, skin aging, rejuvenation, vulva
